To the best of our knowledge, this is the first study that comprehensively examined the significance of DDR2 and collagen type I. When we immunolocalized DDR2 and collagen type I in 224 human breast cancer tissues, their immunoreactivity was significantly increased in carcinoma cells or cancerous stroma compared to normal breast epithelium or stroma. This evidence concerns the gene DDR2 and breast cancer.